Pirfenidone is a medication used to treat idiopathic pulmonary fibrosis. In a randomized, phase II trial from ASTRO 2024, 134 patients with grade 2-3 radiation induced lung injury were randomized to receive standard therapy with or without pirfenidone. Patients who received pirfenidone had significant improvement in multiple PFT measures as well as CT imaging features of RILI. However, symptoms such as cough and dyspnea were similar between groups. | Chen, ASTRO 2024

